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Abstract 
The intestinal lamina propria (LP) contains a diverse array of mononuclear phagocyte 
(MNP) subsets, including conventional dendritic cells (cDC), monocytes and tissue 
resident macrophages (mI) that collectively play an essential role in mucosal 
homeostasis, infection and inflammation. In the current review we discuss the 
function of intestinal cDC and monocyte derived MNP, highlighting how these 
subsets play several non-redundant roles in the regulation of intestinal immune 
responses. While much remains to be learnt, recent findings also underline how the 
various populations of MNP adapt to deal with the challenges specific to their 
environment. Understanding these processes should help target individual subsets for 
‘fine tuning’ immunological responses within the intestine, a process that may be of 
relevance both for the treatment of inflammatory bowel disease and for optimized 
vaccine design.  
 
Defining murine intestinal mononuclear phagocyte subsets 
 
Conventional dendritic cells (cDC) and macrophages (mI) are found 
throughout the intestinal LP, but much remains to be understood about the precise 
function of each cell type. In part this is because they are difficult to isolate, but to a 
great extent, it reflects the imprecise ways in which they were identified until 
recently.1-3 Thus it is now clear that markers such as CD11c, CD11b and MHCII are 
not sufficient to distinguish between cDC and mI in many tissues, including the 
intestine. This is because most mature intestinal mI express as high levels of all these 
molecules as cDC and distinguishing these cells correctly, requires the additional use 
of markers that are specific to mI such as CD64 (FcJRI), F4/80 or Mer tyrosine 
kinase (MerTK).2, 4-6 Initial ideas that CD103 (integrin DE) and CX3CR1 (fractalkine 
receptor) could be used to identify intestinal cDC and mI respectively have also 
proved incorrect, as it is now clear that not all cDC in the intestine express CD103 
and that some also express CX3CR1. 
Intestinal LP cDC can be identified as lineage (CD3, CD19, B220, NK1.1, 
CD64) negative cells that express CD11c and major histocompatibility class II 
(MHCII) (Table 1; Figure 1 A-B).7, 8 In compliance with the current definition of 
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cDC these cells express FMS-like tyrosine kinase 3 (FLT3/CD135), the receptor for 
the cDC-specific growth factor FLT3 ligand (FLT3L) and show dependence on this 
receptor-ligand pathway for their development from cDC precursors in the BM.8, 9 
They also express the zinc finger and BTB domain containing 46 (Zbtb46) 
transcription factor (TF),8, 10 have a lifespan in the tissue of only a few days, and have 
the capacity to migrate in afferent lymph to the draining lymph nodes, where they can 
prime naïve T cells.2, 3, 5 In contrast, cells of the monocyte-mI lineage are 
CD64+CD11b+ (Table 2; Figure 1 A, D), are independent of FLT3 signalling, but 
require the colony stimulating factor 1 receptor (CSF-1R/CD115) for development.11 
They are derived from monocytes or embryonic stem cells and in steady state they 
have a lifespan of several weeks in tissues, do not migrate in lymph and have little or 
no ability to prime naïve T cells.2, 4 Wherever possible, we will discuss intestinal cDC 
and mI that have been identified based on these parameters, but caution needs to be 
used when interpreting the many studies in the field that have not applied such 
rigorous strategies.  
 
PART A. Intestinal cDC 
 
 
While Peyer’s patches (PP) contain a sizeable population of cDC, the current 
review focuses on those cDC that are diffusely distributed throughout the intestinal 
LP. It should however be noted that intestinal LP cell preparations will contain cDC 
from ‘contaminating’ isolated lymphoid follicles (ILF). As the major antigen 
presenting cells (APC) of the immune system, intestinal cDC continually sample their 
environment for foreign (food proteins, microbes) and self-antigens.12-18 In addition to 
uptake of apoptotic or damaged cells, several mechanisms have been proposed for 
how intestinal cDC acquire antigen from the lumen including the extension of trans-
epithelial dendrites into the lumen,19 via goblet cell associated antigen-passages 
(GAPs),20, 21 indirectly via villus M cells,22 or after transfer from tissue resident mI23 
Some soluble materials may also be taken up by cDC after crossing the epithelium by 
paracellular or transcellular mechanisms.24 After acquiring antigen, cDC migrate in a 
chemokine receptor 7 (CCR7) dependent manner via afferent lymphatics to intestinal 
draining mesenteric lymph nodes (MLN), where they present processed antigen to 
cells of the adaptive immune system.15, 17, 18, 25, 26 T cells activated in MLN are 
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induced to express a ‘gut homing’ CCR9+D4E7+ phenotype,27, 28 in part through the 
action of retinoic acid (RA) derived from migratory intestinal cDC and/or local 
stromal cells.25, 29-31 In the steady state intestinal cDC are considered to be 
tolerogenic, a property that appears to be maintained, at least in part through MAP 
kinase p38D32 transforming growth factor E receptor II (TGFERII) signalling,33 
tumor necrosis factor receptor associated factor 6 (TRAF6),34 E-catenin signalling,35 
as well as the signalling regulator A20 (TNFAIP3).36, 37 In this state, presentation of 
innocuous antigens by cDC promotes the generation of forkhead box P3+ (FoxP3+) 
inducible Treg (iTreg) in MLN and is key to the development of oral tolerance to 
dietary proteins and for maintaining the symbiotic relationship with the microbiota.18, 
38-40 Intestinal cDC also express a wide array of cytokine and pattern recognition 
receptors (PRRs), allowing them to respond to local inflammatory cues and microbial 
products and so to initiate active immunity when necessary. Notably the various 
individual subsets of intestinal cDC (see below) are equipped with distinct 
combinations of PRRs, and thus may respond to microbes in different ways.41-47 
 
Phenotype and Ontogeny of Intestinal cDC subsets 
 
Intestinal cDC are highly heterogeneous and recent years have seen great 
progress in our understanding of intestinal cDC subset development and functions. 
Although early work assumed that intestinal cDC comprised a homogeneous 
population of CD103+ cells, this is now known to be an over-simplification and most 
recent studies have divided them on the basis of CD103 and CD11b expression. This 
reveals 3 major (CD103+CD11b-, CD103+CD11b+, and CD103-CD11b+) and one 
minor (CD103-CD11b-) cDC subsets, all of which express the TF ZBTB46, are 
dependent on FLT3L for development in vivo and are derived from a pre-cDC 
precursor.8, 10, 13 Importantly all four populations of CD103+CD11b-, CD103+CD11b+, 
CD103-CD11b+, CD103-CD11b- intestinal cDC can be found in the migratory 
compartment of intestine draining LN, as well as in pseudo-afferent lymph draining 
the steady state intestine.8, 10, 13, 14 Thus each has the potential of initiating and 
regulating adaptive immune responses within LN.  
Apart from CD103-CD11b- cDC, all the other cDC subsets are present in the 
intestinal-draining lymph of RA-receptor related orphan receptor Jt deficient mice 
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(Rorc-/-), which lack ILF and PP,13 suggesting that they derive from the LP. Since this 
minor population of CD103-CD11b- DCs appears heterogeneous and its functions are 
unknown, it will not be discussed further here.  
The proportions of CD103+CD11b-, CD103+CD11b+, CD103-CD11b+ LP cDC 
differs markedly along the length of the intestine. For example CD103+CD11b+ cDC 
make up the major proportion of cDC in the small intestine, but constitute only a 
minor fraction of cDC in the colon, where CD103+CD11b- cDC predominate.48, 49 
While these differences may reflect the distinct physiological requirements of these 
tissues and variations in the environmental conditioning factors present in each site 
(see below), the functional consequences remain to be explored.  
 
Parallel studies have demonstrated that cDC across tissues can be split into 
two major branches of X-C motif chemokine receptor 1 (XCR1) or signal regulatory 
protein D (SIRPDCD172a) expressing cDC. Such studies have resulted in a unifying 
nomenclature for XCR1+ cDC as cDC1 and SIRPD+ cDC as cDC2.9, 41, 50 Murine 
cDC1, but not cDC2, are dependent on the TFs interferon regulatory factor 8 (IRF8), 
basic leucine rich zipper transcription factor ATF-like 3 (BATF3) and inhibitor of 
DNA-binding 2 (ID2) for their development, while absence of the TFs interferon 
regulatory factor 4 (IRF4), neurogenic locus notch homolog protein 2 (NOTCH2), 
RelB and Krüppel like factor 4 (KLF4) impacts negatively on the development of 
cDC2 (see accompanying review by Sichien et al). XCR1 and SIRPD expression also 
splits the murine intestinal cDC compartment into two major populations. Intestinal 
XCR1+ cDC are almost entirely CD103+CD11b- with a very minor population being 
CD103-CD11b- (Figure 1 B-C). As with extra-intestinal XCR1+ cDC, intestinal 
CD103+CD11b- cDC express IRF8,7 and their generation is dependent on the TFs 
IRF8, ID2 and BATF3.7, 12, 51, 52 Of note, mice that are haplo-insufficient in Irf8 have 
normal numbers of intestinal and migratory CD103+CD11b- cDC in MLN, but 
severely reduced numbers of MLN resident XCR1+ cDC, indicating some differences 
in IRF8 dependency between XCR1+ cDC populations.7 Intestinal SIRPD+ cDC are 
more heterogeneous and include major populations of CD103+CD11b+ and CD103-
CD11b+ cDC, together with a small group of CD103-CD11b- cDC (Figure 1 B-C). 
CD11c-targeted deletion in Irf4 leads to a partial reduction of CD103+CD11b+ cDC in 
the small intestinal LP and an absence of these cells in the MLN 53 as well as reduced 
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numbers of CCR2 expressing CD103-CD11b+ DCs.8 Further, mice whose CD11c+ 
cells are deficient in Notch2 display reduced numbers of CD103+CD11b+ cDC in the 
small intestine and MLN,10, 54 while deficiency in Klf4 results in reduced proportions 
of small intestinal CD103+CD11b+ cDC and both migratory and LN-resident SIRPD+ 
cDC in MLN.55 Whether intestinal CD103-CD11b+ cDC numbers are also altered in 
the absence of Klf4 or Notch2 remains to be determined using rigorous gating 
strategies 10, 54. It also remains unclear whether, and at what point, these TFs interact 
to regulate CD103+CD11b+ cDC development. Finally mice with deficiency of Zinc 
finger E-box-binding homeobox TF 2 (Zeb2) in CD11c+ cells show a reduced 
proportion of CD103-CD11b+ cDC within the intestine but not MLN and normal 
proportions of intestinal and MLN CD103+CD11b+ cDC, although the absolute 
number of each of these SIRPD+ cDC subsets was not assessed.56  
In preliminary studies we have found that the transcriptomes of small 
intestinal CD103-CD11b+ and CD103+CD11b+ cDC differ by only 100-200 genes and 
that absence of TGFERI signalling in CD11c+ cells leads to a marked reduction in 
small intestinal CD103+CD11b+ cDC and a concomitant accumulation of CD103-
CD11b+ cDC (Montgomery, Bain et al. submitted for publication). Collectively these 
findings indicate that these subsets are closely related to one another and that steady 
state TGFER signalling drives the differentiation of at least some CD103-CD11b+ 
cDC into CD103+CD11b+ cDC. Nevertheless given the heterogeneity in phenotype, 
TF requirements and function of intestinal SIRPD+ cDC we refer to these intestinal 
cDC populations below as XCR1+ or SIRPD+ cDC, rather than cDC1 and cDC2. 
 
 
Functions of intestinal cDC subsets 
 
Non-redundant functions of intestinal XCR1+ cDC  
Several mouse models have been utilized to draw conclusions on the in vivo 
function of intestinal XCR1+ cDC including Batf3-/-, and more recently Cd11c-
cre.Irf8fl/fl, Zbtb46-cre.Irf8fl/fl, Xcr1-DTA, and Clec9a-DTR mice.7, 38, 45, 51, 57 While 
each of these models results in a marked or complete depletion of intestinal XCR1+ 
cDC, findings from these studies should be taken with a degree of caution, as direct 
effects on additional cell types have often not been ruled out. It can also be unclear 
whether the consequences of deletion reflect absence of XCR1+ cDC in the intestine 
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or other tissues. Nevertheless, these models have greatly extended our understanding 
of the biological function of XCR1+ cDC and demonstrate that they play key non-
redundant roles in regulating multiple aspects of the intestinal immune response.   
Cd11c-cre.Irf8fl/fl and Xcr1-DTA mice have reduced numbers of CD4+ and 
CD8+ LP T cells and conventional CD8DE+TCRDE+ and unconventional 
CD8DD+TCRDE+ and CD8DD+TCRJG+ intra-epithelial lymphocytes (IEL) in the 
small intestine.7, 57 Several mechanisms by which XCR1+ cDC potentially support 
small intestinal T cell homeostasis have been identified. Firstly small intestine derived 
CD103+CD11b- cDC in MLN appear to be the major source of cDC derived RA,7 a 
key inducer of CCR9 and D4E on responding T cells, and their absence results in a 
reduced generation of CCR9+D4E7+ small intestinal homing T cells.7 Secondly, 
XCR1+ DC play a dominant role in cross-presenting intestinal epithelium-derived 
cell-associated antigen to CD8+ T cells in steady state,14 and are required for optimal 
CD8+ T cell responses to orally administered protein antigen and rotavirus infection.7, 
58 Thus reduced CD8+ T cell priming may contribute to reduced numbers of small 
intestinal CD8DE+ T cells. Finally, XCR1 and XCL1 deficient mice also display a 
selective reduction in small intestinal TCRDE+ T cells. Here, crosstalk between XCR1 
on intestinal CD103+CD11b- cDC and XCL1 expressing T cells appears to promote 
intestinal T cell survival as well as modulate CD103+CD11b- cDC maturation, 
promoting their migration to the MLN.57 
Intestinal XCR1+ cDC are also required for the generation and maintenance of 
particular intestinal CD4+ T cell subsets. Small intestinal CD4+ T cells in Xcr1-DTA 
mice have reduced levels of IFN-J mRNA57 and the small intestine and colon LP of 
Cd11c-cre.Irf8fl/fl mice have a dramatic reduction in Th1 cells.7 These mice also fail 
to generate colonic Th1 responses to the colonic dwelling protozoan Trichomonas 
musculis.59 One explanation for the reduction in intestinal Th1 cells in the absence of 
XCR1+ cDC is defective Th1 cell generation in MLN.7 While the mechanisms 
underlying this defect remain to be determined, one possibility is that a loss of XCR1+ 
cDC results in reduced levels of IL-12. Consistent with this idea, CD103+CD11b- 
cDC are the major cDC source of IL-12 in the MLN in the steady state60 and during 
acute GvHD.61 Further IL-12 production by CD103+CD11b- cDC is required for 
driving IFN-J production in T and NK cells during Toxoplasma gondii infection,62 
while IL-12 and IL-15 production by colonic CD103+CD11b- cDC has been 
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implicated in driving tonic release of IFN-J by intestinal T cells, promoting epithelial 
resistance to dextran sodium sulfate (DSS) induced colitis.45 Of note, deletion of the 
A20 inhibitor of nuclear factor-NB (NF-NB) activation in CD11c-expressing cells 
leads to up-regulation of the co-stimulatory molecules CD80 and CD86 on 
CD103+CD11b- cDC and unleashes their ability to drive massive IFN-J production 
by CD4+ T cells. Therefore in the steady state this signal attenuator may normally 
limit the capacity of XCR1+ cDC to drive Th1 cell differentiation.37  
Cd11c-cre.Irf8fl/fl, Xcr1-DTA and Batf3-/- mice also lack CD4+CD8DD+IEL,7, 
57, 63 a population of MHCII restricted cytotoxic T cells whose development from 
conventional CD4+ T cells requires TGFE and RA.64, 65 We recently demonstrated that 
this process also requires CD103+CD11b- cDC expression of the DvE8 integrin,7 
involved in the activation of the latent TGFE complex.66 Interaction between cell 
adhesion molecule 1 (CADM1) on intestinal CD103+CD11b- cDC and class 1-
restricted T cell adhesion molecule (CRTAM) on intestinal CD4+ T cells has also 
been implicated in the generation of CD4+CD8DD+ IEL,63 although intestinal mI also 
express CADM1 (based on IMMGEN.org database and authors unpublished 
observation) and so could also contribute to local differentiation of this population.  
Finally, CD103+CD11b- cDC are required for the optimal generation of iTreg in 
MLN following oral administration of protein antigen.38 This could reflect the high 
capacity of CD103+CD11b- cDC to generate RA7, 67 and TGFE2 mRNA,38 as well as 
their expression of the highest levels of DvE8 integrin amongst intestinal cDC,7, 38, 68 
all factors that are associated with iTreg conversion. However the overall significance 
of these findings remains to be elucidated, as mice deficient in XCR1+ cDC display 
normal proportions of endogenous FoxP3+ Treg in the intestine7, 51, 57, 69, 70 and develop 
oral tolerance normally.38  
 
Non-redundant functions of SIRPD+ cDC subsets 
 Models that have been utilized to draw conclusions on the in vivo functions of 
SIRPD+ cDC include Cd11c-cre.Irf4fl/fl,53, 71 Cd11c-cre.Notch2fl/fl,10, 54 Cd11c-
cre.Klf4fl/fl,55 Clec4a4-DTR45, and SirpD-/- mice;72 as well as huLangerin-DTA mice 
that express Diphtheria toxin A (DTA) under the control of the human Langerin 
promoter, which is primarily active in intestinal CD103+CD11b+ cDC.70 Notably, 
none of the above models show depletion in all intestinal SIRPD+ cDC. Further it is 
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important to bear in mind that changes in immunological responses observed in mice 
with CD11c-Cre mediated deletion of Irf4, Notch2 or Klf4 may not necessarily be due 
to depletion of a particular SIRPD+ cDC subset, but could reflect an impact on cDC 
function. Of further note, as our understanding of MNP subsets has advanced, it 
remains possible that functions ascribed previously to cells of the monocyte-
mIlineage through the use of for example Ccr2-/- and Cx3cr1-DTR mice may in fact 
be a function of SIRPD+ cDC, as some of these cells express CCR2 and intermediate 
levels of CX3CR1; the numbers of several SIRPD+ cDC subsets are also markedly 
reduced in these animals.8, 73  
Cd11c-cre.Irf4fl/fl, Cd11c-cre.Notch2fl/fl and SirpD-/- mice display a selective 
reduction in intestinal Th17 cells,53, 54, 71, 72 collectively suggesting a key role for 
SIRPD+ cDC in intestinal Th17 cell homeostasis. Cd11c-cre.Irf4fl/fl mice also fail to 
generate colonic Th17 responses to Trichomonas musculis.59 Further, huLangerin-
DTA mice have reduced numbers of small intestinal Th17 cells, suggesting that loss 
of CD103+CD11b+ cDC underlies Th17 deficiency at this site, although MHCII 
expression by these cells may not be required.70  
 While the mechanisms underlying reduced intestinal Th17 cell numbers in the 
above models remains unclear, one likely contributing factor is reduced Th17 
differentiation in intestinal draining lymph nodes. Thus Cd11c-cre.Irf4fl/fl mice fail to 
support Th17 differentiation in MLN following immunization with antigen and 
adjuvant.53 Mechanistically, Th17 priming under these conditions is IL-6 dependent 
and absence of small intestinal derived migratory CD103+CD11b+ cDC in MLN 
of Cd11c-cre.Irf4fl/fl mice leads to reduced levels of cDC derived IL-6.53 Consistent 
with these findings small intestinal LP CD103+CD11b+ cDC but not CD103+CD11b-
 cDC from Cd11c-cre.A20fl/fl mice spontaneously produce large amounts of IL-6 and 
drive IL-6 dependent Th17 differentiation in vitro.37  
Recent studies have also shown that CD103-CD11b+ cDC, and in particular 
CCR2+CD103-CD11b+ cDC, are capable of driving Th17 cell differentiation in vitro.8, 
74 Since CD103-CD11b+ cDC are the dominant SIRPD+ cDC in the colon and colon 
draining nodes,49 it remains plausible that these cells play an important role in colonic 
Th17 cell homeostasis, although this remains to be addressed experimentally. 
Interestingly Cd11c-cre.Klf4fl/fl mice, that also have reduced numbers of intestinal 
SIRPD+ cDC appear capable of mounting normal intestinal Th17 cell responses,55 
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suggesting that KLF4 may be involved in the development of a distinct SIRPD+ cDC 
subset or regulate distinct functional modules in these cells. 
Despite the clear role for SIRPD+ cDC in intestinal Th17 cells homeostasis, 
some Th17 cells remain in the LP in all the models above. This may be because 
SIRPD+ cDC are not completely depleted in these models, or that additional MNP 
subsets contribute to driving intestinal Th17 responses. Consistent with this latter 
possibility, Th17 responses to the intestinal commensal segmented filamentous 
bacteria (SFB) require input from intestinal mI.75  
 In addition to their role in Th17 homeostasis, IRF4-dependent SIRPD+ cDC are key 
for the development of Th2 responses. While studies on intestinal Th2 responses 
remain limited, Cd11c-cre.Irf4fl/fl mice do not develop a protective Th2 response to 
the parasitic worms Nippostrongylus brasiliensis76 or Trichuris muris (Meyer et al., 
manuscript submitted). Further, in collaboration with the group of Dr. S. Milling 
(University of Glasgow), we recently identified a key role for migratory 
CD103+CD11b+ cDC in initiating Th2 responses in small intestinal draining MLN in 
response to subserosal injection of Schistosoma mansoni eggs into the small intestine. 
In contrast, migratory CD103-CD11b+ cDC drove Th2 responses in colonic draining 
MLN after subserosal egg injection into the colon (Meyer et al., manuscript 
submitted). Thus the SIRPD+ cDC subset responsible for driving Th2 immunity may 
depend on where in the intestine the infection takes place. Notably, Cd11c-cre.Klf4fl/fl 
mice also have impaired Th2 responses,55 collectively suggesting that KLF4 
expression in IRF4 dependent SIRPD+ cDC is required for the development of Th2 
immunity.  
 Finally, several reports have suggested a role for intestinal SIRPD+ cDC in 
regulating innate lymphoid cell (ILC) functionality. Intestinal CD103+CD11b+ cDC 
produce IL-23 following challenge with flagellin or in response to Citrobacter 
rodentium (C.rodentium) infection, driving IL-22 expression by intestinal resident 
type 3 innate lymphoid cells (ILC3).10, 77 However CD103-CD11b+ cDC and intestinal 
mI can also produce IL-23 and the relative importance of these MNP subsets as a 
source of IL-23 may depend on the model and the intestinal location under study.70, 73, 
77-80 
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Cooperation and antagonism between intestinal cDC subsets  
 Although XCR1+ and SIRPD+ cDC have non-redundant functions in intestinal 
immune homeostasis, there is also evidence of cooperation between these subsets. For 
example, while intestinal FoxP3+ Treg are found in normal numbers in Cd11c-
cre.Irf4fl/fl and huLangerin-DTA mice,53, 70 mice lacking XCR1+ cDC and 
CD103+CD11b+ cDC, have decreased numbers of Treg in the small intestine.70  
Further, iTreg generation in MLN in response to orally administered soluble protein 
antigen is reduced in Zbt46-cre.Irf8fl/fl mice, that lack XCR1+ cDC, while almost 
absent in diphtheria toxin treated Zbt46-DTR mice, that lack all cDC, however only 
Zbtb46-DTR mice fail to develop oral tolerance.38 iTreg generation to commensal 
antigens is also dependent on cDC and here, NOTCH2-dependent SIRPD+ cDC rather 
than XCR1+ cDC appear to play a dominant role.81 Finally while XCR1+ cDC are the 
superior cross-presenting APC subset, there may also be redundancy in the induction 
of CTL responses in a setting of infection. Thus CD8+ T cell responses to rotavirus 
are only partially reduced in Batf3-/- mice lacking XCR1+ cDC, but are completely 
ablated in Zbt46-DTR mice depleted of all cDC.58  
 Two recent studies have also provided evidence of antagonism between intestinal 
XCR1+ and SIRPD+ cDC. Firstly, IL-12 production by XCR1+ cDC appears to reduce 
the Th2 response to Heligmosomoides polygyrus infection60 and secondly, IL-23 
production by CX3CR1+ cDC and mI reduces IL-12 production by XCR1+ cDC 
during C.rodentium infection, protecting mice from Th1 cell mediated fatal 
immunopathology.73 These results suggest that cDC subsets can mutually dampen 
each other’s responses, probably to help prevent excessive immune activation and to 
maintain a balanced immune response. A summary of the reported functionality of 
intestinal XCR1+ and SIRPD+ cDC can be seen in Figure 2 and Table 1. 
 
Human cDC 
 
Three putative cDC subsets have been identified in the human small intestine 
that can be distinguished based on differential expression of CD141, CD103 and 
SIRPD, together with a lack of the monocyte-macrophage markers CD64 and/or 
CD14.3, 42, 82 Comparative transcriptome profiling revealed close similarity between 
the two major human and murine cDC subset; human small intestinal CD103+SIRPD- 
  12 
cDC resemble CD141+ cDC in other human tissues and murine intestinal 
CD103+CD11b- cDC, while human small intestinal CD103+SIRPD+ cDC resemble 
human blood/tissue derived CD1c+ cDC and murine CD103+CD11b+ cDC. As in the 
mouse, CD103-SIRPD+ cells are also present in the human intestine, the majority of 
which express IRF4, CD11b and intermediate levels of CX3CR1.8, 42 They are also 
heterogeneous for CCR2 expression, suggesting these may be equivalent to murine 
CD103-CD11b+ cDC.8 Surprisingly however, at the transcriptional level, these cells 
appeared to be more related to monocytes,42 indicating that they may represent a 
mixed population of cells due to insufficient gating criteria to exclude all monocyte 
derived populations. Consistent with this possibility, Guilliams and co-workers 
recently provided evidence that CD14-SIRPDhi cells in human lung and intestine 
contain both CD1c-IRF4loIRF8lo monocyte derived cells, as well as bona fide 
CD1c+IRF4hi cDC.83  Because of these findings we confine our discussion on the 
function of human intestinal cDC below to the CD103+SIRPD+ and CD103+SIRPD- 
cDC subsets.  
As in mice, human intestinal CD103+SIRPD+ and CD103+SIRPD- cDC 
express CCR7, indicating they have the potential to migrate to draining LN.42, 82 In 
line with this, CD103+CD141+ and CD103+CD1c+ cDC can both be found within the 
migratory compartment of human MLN.84 The few studies that have assessed the in 
vitro functions of human intestinal cDC subsets thus far have highlighted both 
similarities and differences compared with their mouse homologues. As in mice, 
human small intestinal derived cDC induce RA-dependent expression of D4E7 and 
CCR9 on responding T cells and those from the small intestine imprint CCR9 
expression on responding T cells more efficiently than colonic cDC.31, 82 Human 
small intestinal CD103+SIRPD+ cDC display higher aldehyde dehydrogenase activity 
and induce CCR9 on responding T cells in vitro more efficiently than CD103+SIRPD- 
cDC.42 This former population also has the highest capacity to induce FoxP3 
expression on CD4+ T cells, whereas CD103+SIRPD- cDC appear more efficient at 
inducing Th1 differentiation.42 While the role of human cDC subsets in intestinal 
inflammation and infection remains to be determined, perturbations in the cDC 
compartment in inflamed mucosa and MLN have been observed in patients with 
Crohn’s disease and ulcerative colitis.84 Altered aldehyde dehydrogenase activity in 
intestinal cDC has also been reported in human inflammatory bowel disease (IBD), 
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although there is contradictory evidence about whether it is increased or reduced 
under these circumstances.84, 85 A recent study identified a panel of lineage specific 
markers suggested to identify XCR1+ cDC (CADM1hi SIRPDlo CD11cint-hi CD26hi 
IRF8hi IRF4lo) and SIRPD+ cDC (CADMlo SIRPDhi CD1chi CD11chi IRF4hi IRF8lo) 
across species and tissues that should prove useful in comparative phenotypic and 
functional studies between human and murine intestinal cDC subsets.83 
 
Environmental Conditioning of Intestinal cDC 
 
Intestinal cDC have many characteristics which set them apart from their 
counterparts in other tissues, indicating that their development and functional 
specialisations may involve tissue-specific factors. The same cDC subsets also display 
distinct characteristics depending on their location within the intestine, probably 
reflecting the differences in anatomy, function, microbial composition and nature of 
micronutrients that are found along the length of the intestine.86  
The presence of large numbers of CD103+CD11b+ cDC in the murine small 
intestine is perhaps the most obvious example of how the cDC lineages differ between 
the intestine and other tissues. As we have discussed, this appears to be at least partly 
due to tonic TGFE signals, although the source and molecular basis of this effect are 
unclear (Montgomery et al., submitted for publication). Several dietary and bacterial 
metabolites have also been implicated in regulating intestinal cDC development and 
function. For example, RA has a major impact on the function of murine intestinal 
cDC, particularly in the small intestine. Tissue retinol levels are highest in the small 
intestine, due to uptake from the diet and potentially through delivery of liver-stored 
retinol via the bile, resulting in an increase in RA signalling in small intestinal cDC.87-
89 Such signalling induces aldehyde dehydrogenase 1a2 (Aldh1a2) expression in small 
intestinal cDC endowing them with the capacity to generate CCR9+D4E7+ small 
intestinal homing T cells.30, 31, 90, 91 Both epithelial cells and local stromal cells in the 
small intestinal LP have been implicated in the conversion of retinol to RA for 
delivery to local cDC.88, 92 Vitamin A deficient mice, or mice whose CD11c+ cells are 
unable to respond to RA also display reduced numbers of intestinal CD103+CD11b+ 
cDC 93 and in particular intestinal CD103+CD11b- cDC in these mice, start to express 
langerin, 93, 94 indicating an additional role for RA in regulating intestinal cDC 
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development. Consistent with this, RA has been proposed to promote the 
development of ‘gut homing’ pre-cDC in the bone marrow,95 and to participate in the 
imprinting of an ‘intestine-like’ phenotype on pre-cDC subsequent to their entry into 
the intestine.93, 95 Additional metabolites implicated in modulating intestinal cDC 
function include AhR ligands and short chain fatty acids (SCFAs). For example mice 
lacking AhR on CD11c+ cells display minor alterations in intestinal cDC subset 
composition and their cDC display altered expression of Wnt signalling 
components,96 while butyrate signalling through the G-protein coupled receptor 
GPR109A may impart an anti-inflammatory profile on colonic cDC, promoting their 
ability to generate iTreg and IL-10 producing T cells.97 
 
 
PART B: Intestinal Macrophages 
 
Macrophages defined using the phenotypic and functional criteria discussed above 
are found throughout the gastrointestinal tract from before birth onwards.6, 98, 99 Most 
intestinal mI are found in the LP in close proximity to the epithelium and some may 
extend processes into the epithelial layer itself (see below). Discrete populations of 
mI are also present within the muscularis externa and serosa, where they engage in 
two-way interactions with the enteric nervous system,100-103 but here we will confine 
our discussion to the mI present in the intestinal mucosa. MI are relatively more 
abundant in the colon than small intestine,86 while those expressing high levels of 
CD11c may be found closer to the epithelium than the CD11c- subset.104 A specific 
population expressing CD169 (sialoadhesin) is typically found near the crypt base, 
close to the submucosa and may have distinct functions and developmental 
requirements (105, 106 and see below). 
 
Ontogeny of Intestinal Macrophages 
Like resident mI in other tissues, mature mI in the intestinal mucosa are large, 
vacuolated cells with abundant cytoplasm containing lysosomes and other granules.4 
In mice they express classical mI markers including CD11b, CD64, MERTK and 
F4/80, but unlike mI in many other tissues, virtually all those in the intestine also 
express high levels of MHCII and CX3CR1. Most are also CD11c+ (Table 2).4, 107, 108  
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Tissue resident mI derive from a number of different precursors, including 
mesenchymal stem cells in the embryonic yolk sac (YS), foetal liver monocytes and 
adult bone marrow (BM) derived monocytes, with the relative contribution of each 
precursor source varying from organ to organ (see 109 for review). Although 
embryonically derived mI are present in the mouse intestine at birth, BM derived 
Ly6Chi (“classical”) monocytes appear soon afterwards. Using a variety of 
approaches, we and others have shown that adult intestinal mI are entirely of 
haematopoietic origin and require constant replenishment by Ly6Chi monocytes.4, 6, 107 
This process is dependent on CCR2, which is not only needed for emigration of 
Ly6Chi monocytes from the BM,4, 77, 107, 110 but also for their recruitment to the 
intestine.111 Thus while Ly6Chi monocytes were originally considered to be involved 
only in inflammatory processes, it is now clear that they can also give rise to tissue 
mI under either steady state or inflammatory conditions.107 
In contrast to these studies, it has been reported that a subpopulation of CD11c- 
mature intestinal mI cannot be replenished by CCR2-dependent monocytes, although 
the exact origin of these mI was not examined directly.80, 104 It has also been reported 
that intestinal mI may be dependent on CX3CR1,112, 113 whose function is required 
for the survival of the alternative group of Ly6Clo monocytes.114 However in our 
hands, this population of monocytes could not be found entering the intestine and 
Cx3cr1-/- mice had normal numbers of intestinal mI.107 The reasons for these 
discrepant results are unclear, but they could indicate that the relative contribution of 
different precursors to the intestinal mI pool may vary depending on factors in the 
environment, such as the nature of the microbiota.  
An important point to note here is that the embryonic mI present at birth share 
many of the characteristic properties of their monocyte-derived counterparts in adult 
intestine including high phagocytic activity, production of IL-10 and expression of 
scavenger receptors.115 Furthermore adult CD11c+ and CD11c- mI differ by 
expression of only a few genes.104 These findings are consistent with the emerging 
view that location and not origin defines the functions of tissue resident mI.109, 116  
After arrival in the mucosa, monocytes undergo a process of local differentiation 
through a series of phenotypic intermediaries known as the monocyte “waterfall”.6, 107 
In mice this can be followed phenotypically, with CX3CR1intLy6ChiMHCII- 
monocytes (“P1”) first acquiring MHCII (“P2”), before losing Ly6C expression 
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(“P3”) and finally acquiring the CX3CR1hiLy6C-MHCIIhi phenotype of mature 
resident mI (“P4”) (Figure 1 D). In mouse colon this differentiation process takes 
around 5-6 days from when the monocytes first enter, with the mature mI having an 
estimated t1/2 of 6-8 weeks.4, 117 As with most resident tissue mI, this developmental 
process in the intestine requires the CSF-1R.11  
 The properties of fully mature intestinal mI are acquired progressively as they 
develop through the local differentiation process described above (Table 2; Figure 
3). Consistent with their morphological appearance, they express high levels of 
receptors associated with the recognition and uptake of apoptotic cells or opsonised 
organisms, including CD163 (haem/haptoglobin scavenger receptor), CD206 
(mannose receptor), CD36, scavenger receptor A (SRA), the receptor tyrosine kinases 
Axl and MerTK, the complement complex C1Q, T-cell immunoglobulin mucin 
protein 4 (TIM4) and DvE5 integrin (107, 118, 119 and Kumawat, Mowat, Unpublished 
observations). In parallel they are avidly phagocytic and bactericidal even without 
additional stimulation.4, 118-121 Under steady state conditions they also produce 
mediators such as TNFD, IL-1E and IL-10, with up to 50% of mature intestinal mI 
producing IL-10 constitutively.107, 117, 122-124  
Despite this evidence of being activated in situ, intestinal mI fail to respond to 
agents that normally activate mI by producing pro-inflammatory cytokines, nitric 
oxide (NO) or reactive oxygen intermediaries (ROI). The unresponsiveness is global 
in extent, as it also applies to non-Toll like receptor (TLR) stimuli such as IFNJ and 
NOD2 ligands or when mI have taken up pathogens.107, 121, 125-128 These properties 
allow intestinal mI to act as efficient scavengers without generating the inflammation, 
which normally ensues upon encounter of microbes and would compromise intestinal 
homeostasis.  
A variety of factors in the local environment have been implicated in maintaining 
the anergy of intestinal mI, including downregulation and/or active inhibition of TLR 
signalling pathways, despite normal expression of the TLRs121, 129, 130 and other 
pattern recognition receptors.107, 121 Mice lacking IL-10 or its receptor develop 
microbiota-dependent spontaneous IBD, associated with hyperactivity of intestinal 
mI104, 122, 131-134 and lack of signalling via the IL-10R on mI leads to spontaneous 
colitis.122, 134, 135 Mutations in this pathway are associated with severe, early onset IBD 
in humans.136-138 IL-10 has many anti-inflammatory effects on myeloid cells, 
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including epigenetic silencing of inflammatory gene loci via the activation of histone 
deacetylase (HDAC).139, 140 Whether the epigenome of resident intestinal mI shows 
evidence of this gene silencing remains to be determined.   
TGFE has been implicated in the TLR unresponsiveness of human intestinal 
mI,141, 142 but in our hands, mouse intestinal mI that lacked TGFER signalling did not 
show enhanced responses to TLR ligation.143 Therefore there may be species 
differences in how intestinal mI reactivity is controlled. One possibility is that the IL-
10 and TGFE pathways play complementary roles and that these may vary with age. 
This is supported by findings that the effects of TGFE can be observed from late in 
gestation onwards,141 while those of IL-10 appear to develop in a narrow time 
window in early neonatal life.140 In parallel, IBD in IL-10-/- mice can be prevented by 
exogenous replacement of the cytokine in neonatal, but not in adult animals, 
consistent with there being a limited period during which IL-10 can cause epigenetic 
silencing of mI genes.140  
Finally, resident intestinal mI express a variety of inhibitory receptors with the 
potential for restricting their activation in a cell intrinsic manner, such as CD200R, 
SIRPD and Axl. Intestinal mI from mice lacking Axl show evidence of an increased 
inflammatory profile,144 but there are contradictory findings on whether absence of 
CD200-CD200 receptor signalling pathway leads to mI activation or inflammation in 
the intestine.145, 146 In contrast to what is observed with intestinal cDC (see above), 
mice with a mutant form of SIRPD that lacks the signalling domain do not have 
alterations in the intestinal monocytes/mI compartment in steady state intestine and 
are also not susceptible to inflammation (72 and Scott & Mowat, Unpublished 
observations). 
Perhaps surprisingly, intestinal mI retain their global hyporesponsiveness to TLR 
stimulation even when the microbiota is entirely lacking in germ free and embryonic 
mice (115, 139 and our unpublished observations). 
 
Physiological Functions of Intestinal Macrophages  
 
Symbiosis with the Microbiota 
 As mucosal mI are typically found in close proximity to the epithelium and 
are more abundant in colon compared with small intestine, it seems reasonable to 
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assume that one of their main roles in vivo is the uptake and clearance of microbes 
that have crossed the epithelial barrier (Figure 3). Indeed bacteria have been detected 
within lamina propria mI from steady state intestine99 and CX3CR1+ mI account for 
most of the uptake of organisms when E coli are administered orally.147 In this regard 
CX3CR1+ phagocytes have been observed to send processes from the LP across the 
epithelium to capture luminal bacteria in a CX3CL1-dependent manner and although 
originally thought to be cDC,148 it now seems likely that these were mI.108 As noted 
above, intestinal mI are actively bactericidal, possibly reflecting the constitutive 
expression of mediators such as TNFD and metallothionein-dependent Zn2+ cations.149 
Recent work also suggests that CCR2-dependent mI may be required for the 
induction of Th17 cell responses to SFB in steady state intestine.75 Because these 
functions are achieved without causing inflammation, mI are one component of the 
host response that ensures a healthy symbiotic relationship with the commensal 
microbiota. 
 
Maintenance of Epithelial Homeostasis 
The presence of mIin the intestine from before birth and in germ free mice 
indicates they are likely to have physiological functions in addition to scavenging 
bacteria. The intestinal epithelium is one of the most dynamic and rapidly dividing 
tissues in the body and this constant movement and cell loss requires continuous 
remodelling of the underlying extracellular matrix (ECM), as well as disposal of 
effete cells. The high phagocytic activity of intestinal mI is ideally suited to these 
processes and indeed, cytokeratin+ inclusions have been observed within mI from 
steady state intestine (Figure 3).120, 143 Resting intestinal mI also express a variety of 
mediators that can promote tissue remodelling such as metalloproteinases and TNFD 
(Figure 3).150, 151  
That these functions of intestinal mI are necessary to maintain epithelial 
integrity is suggested by studies showing increased epithelial susceptibility to 
inflammatory insults in animals lacking mI themselves or with loss of TLR or AhR 
signalling on myeloid cells.96, 152-154 Furthermore, loss of mIin Csf1-/- mice or 
following depletion with anti-CSF-1R antibody was found to result in dysregulated 
enterocyte differentiation and loss of Paneth cells.155, 156 A similar phenotype has been 
reported in mice lacking AhR expression on CD11c+ cells, suggesting a role for this 
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pathway. However these experiments did not define whether the effects reflected a 
property of cDC, mI or both.96 In this respect, mI have been reported to produce 
several mediators, which could drive intestinal epithelial cell renewal and 
differentiation, including prostaglandin E2 (PGE2), hepatocyte growth factor (HGF) 
and Wnt signalling ligands.96, 157-159  
 
Maintenance of Immunological Homeostasis in the Mucosa 
 The numbers of endogenous FoxP3+ T cells are higher in the colon than small 
intestine, correlating with the relative abundance of mI in each site and mucosal mI 
have been found to stimulate the differentiation of Treg in vitro.48 In part, this may 
reflect their constitutive production of IL-10 and indeed, the fact that a higher 
proportion of mIproduces IL-10 in the colon than in small intestine is consistent with 
the relative abundance of Treg at these sites.122 Intestinal mIderived IL-10 has also 
been implicated in the local expansion of antigen-specific iTreg that have been primed 
in MLN by orally administered protein and accordingly impaired IL-10 production by 
mI in Cx3cr1-/- mice results in a failure to induce oral tolerance.39 In the context of 
inflammation, IL-10 from intestinal CD11b+ cells considered to be mI, has been 
shown to stabilise the function of iTreg by maintaining the expression of FoxP3.123 
TRAF6 expression in CD11c+ MNPs has also been implicated in the generation of 
iTreg in vitro and mice lacking this pathway develop spontaneous Th2 cell-mediated 
intestinal inflammation,34 although it remains to be proven whether the relevant 
CD11c+ cells are mI or cDC in this case. Despite these findings, IL-10 production 
from mI themselves appears not to be essential for preventing spontaneous IBD in 
response to the microbiota.134, 160 Thus although prevention of mI activation via IL-
10R signalling is crucial for preventing inflammatory reactions to the microbiota, 
cells such as CD4+ T cells may be more important sources of the IL-10.  
  Intestinal mI may also be involved in the survival and/or maintenance of 
other immune cells in the mucosa. For instance, IL-1 produced by LP mI in response 
to the microbiota has been reported to drive the production of granulocyte 
macrophage colony-stimulating factor (GM-CSF) from ILC3, which in turn promotes 
intestinal cDC development.161 IL-1E produced by intestinal mI in response to the 
microbiota can also sustain the expansion and survival of IL-17 producing Th17 cells 
in the mucosa.124  
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Mature intestinal mI also produce monocyte specific chemokines such as CCL2, 
CCL7, CCL11 and CXCL16, as well as chemokines that can recruit other immune 
cells.111, 162 Thus resident mI may also regulate their own replenishment and maintain 
a dynamic status quo.  
  
Macrophages and Induction of Adaptive Immune Responses 
Intestinal mI are poor professional APC in vitro and do not express CCR7 or 
migrate in afferent lymph to MLN,2, 13, 108 indicating they are unlikely to play a major 
role in the initiation of adaptive immune responses. However, evidence from other 
systems suggests that antigen-specific T cells require a second stimulus from an APC 
in non-lymphoid tissues to acquire full effector functions.163 Although MHCII+ mI 
would be well placed to serve this function in the mucosa, a role of this kind remains 
to be assessed.  
One way in which mI might contribute indirectly to the priming of mucosal 
immunity comes from evidence that orally administered proteins or bacteria taken up 
by CX3CR1hi mI in LP can be passed to migratory CD103+ cDC.147, 164 In the case of 
protein antigen, this transfer process has been suggested to involve Connexin 43 
(Cx43) mediated gap junctions formed between mI and cDC and leads to the 
induction of oral tolerance.164 Division of labour amongst intestinal mI and CD103+ 
cDC of this kind has also been suggested to be involved in the induction of local Th17 
responses to SFB.75 
 
Macrophages in Intestinal Inflammation  
Disorders such as IBD and infection are accompanied by infiltration with mI and 
monocytes.4 Our own and other work indicates that Ly6Chi monocytes entering the 
intestine fail to differentiate fully to mature mI in the presence of inflammation, 
failing to upregulate IL-10 or to become unresponsive to stimulation.6, 104, 107 In 
addition, there is enhanced recruitment of monocytes above the baseline levels seen in 
steady state intestine and as a result, the early stages of the monocyte waterfall 
(CX3CR1intLy6ChiMHCII+/-) dominate the inflammatory infiltrate.165 Although 
predominantly dependent on the CCL2-CCR2 axis,80, 126, 162, 166-168 other chemokine 
receptors can also come into play in inflammation, including CCR1 and its ligand 
CCL3.169 Contradictory findings have been reported on whether the CX3CR1 
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chemokine receptor plays a role in recruiting inflammatory mI in experimental IBD, 
with both increased and decreased susceptibility having been observed in Cx3cr1-/- 
mice.113, 170, 171 
It is not known why monocytes that arrive in the inflamed mucosa do not go 
through the full differentiation process seen in normal intestine. One possibility is that 
they simply do not survive long enough to be able to progress through the entire 
waterfall, which normally takes up to a week to complete.107 Alternatively there may 
be loss of the factors that usually drive mI survival and development in the healthy 
mucosa. Interestingly, the fate of monocytes may also be determined before they 
arrive in the mucosa, as reported in mice with intestinal toxoplasmosis, where IL-12 
produced by local cDC induces NK cells in the BM to produce IFNJ, leading to 
altered differentiation of monocytes or their precursors.172  
Monocytes and immature mI are the main producers of pro-inflammatory 
mediators such as IL-1, IL-6, TNFD, IL-23, NO and ROI that are found in inflamed 
intestine.6, 80, 104, 117, 119, 134, 145, 153, 166, 168, 169, 173-177 As well as contributing to tissue 
damage directly, these mediators can also recruit and activate additional immune 
effector cells. IL-23 from monocyte derived cells is critical for protective Th17 in 
infections by bacteria such as C.rodentium or Helicobacter hepaticus 73, 173 and 
together with IL-1E it induces the production of antimicrobial and cyto-protective IL-
22 by stimulating ILC3.73, 80 Inflammatory monocytes can also promote ,FNJ and IL-
17 producing Th1 and Th17 cells via the production of IL-12 and IL-6 
respectively.132, 176 As in the steady state, these effects on T cells are likely to involve 
a role in local maintenance of previously primed effector T cells, rather than in 
initiation of the immune response. Pro-inflammatory monocytes/mI also produce 
chemokines such as CCL2, CCL3, CCL4, CCL5, CCL8 and CCL11, which recruit 
monocytes, eosinophils and neutrophils.105, 166, 177  
 It is not clear if pre-existing resident mI can also contribute to these 
inflammatory processes. The resident mI population does not expand markedly in 
chemically induced or T cell dependent colitis and there is little or no change in 
function or gene expression under these conditions.6, 107, 119 Indeed IL-10 secretion by 
intestinal mI is important in limiting IL-23-mediated pathology during experimental 
infection with C.rodentium.122 Nevertheless, resident mI can produce pro-
inflammatory mediators when colitis develops in the absence of IL-10 signalling,134, 
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173 perhaps reflecting retained functional plasticity when IL-10 driven epigenetic 
silencing is lacking.140 It is also possible that there is heterogeneity amongst resident 
mI in their ability to respond to inflammatory stimuli. Indeed the small subset of 
CD169+ mucosal mI expands during inflammation and recruits neutrophils via the 
production of CCL8.105  
 
Intestinal Macrophages and Th2 Mediated Immune Responses 
MI are also important in the Th2 driven immune responses involved in 
resistance to infection by intestinal helminths, when there is infiltration by monocytes 
and expansion of the local mI population.178-182 Under these conditions, production of 
IL-4 and IL-13, together with activation of peroxisome proliferator-activated receptor 
J (PPARJ) by cyclooxygenase-2 (COX2), generates genuine alternatively activated 
mI, with release of typical mediators such as arginase and resistin-like molecule D 
(RELM-D.179, 181, 183, 184 Depletion of monocytes or mature mIinhibits the expulsion 
of helminths,178, 185-187 which may be because mI and their products can attack the 
parasites directly. Alternatively activated mI of this kind also help generate a hostile 
environment by promoting smooth muscle contractility, depriving metabolites such as 
glucose186, 187 and by producing chemokines that recruit additional anti-parasite 
effector cells such as eosinophils.168, 177  
In contrast to what has been described in the pleural or peritoneal cavities,188, 
189 IL-4 and CSF-1 driven proliferation of resident mI does not seem to occur to any 
significant extent during intestinal helminth infection. Under these conditions, most 
mI are derived from Ly6Chi monocytes and only low amounts of local proliferation 
can be observed.181 
  
Monocytes and Macrophages and Resolution of Intestinal Inflammation 
MI play central roles in tissue repair and restoration of homeostasis in 
intestinal inflammation, as depletion of mI delays recovery from experimental 
colitis.152, 154, 190 A variety of mechanisms have been implicated in the repair function 
of intestinal mI, including TLR/MyD88-dependent restoration of the epithelial stem 
cell niche via stimulation of PGE2 production from stromal cells.154, 191 Recovery 
from Heligmosomoides polygyrus induced intestinal pathology also involves mI 
producing chemokine ligands for CXCR2 on fibroblasts, driven in part via CD64.192 
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The ability of mI to induce IL-22 production by ILC3 also favours restitution of a 
damaged epithelial barrier,80, 193 while TGFER mediated suppression of IL-33 
production by mI has been proposed to mediate resolution of chemical colitis.190 
Arginase produced by alternatively activated mI in parasite infections is a further 
important tissue repair mechanism under these conditions.194, 195 Although generally 
thought of as a pro-inflammatory mediator, IL-1E production by myeloid cells has 
also been shown to promote epithelial repair after acute colitis,196 while IL-36 
produced by both mI and epithelial cells may contribute to enhanced turnover of 
enterocytes as a reparative response to inflammation.197  
As many of the properties of resident mI in the healthy intestine would be 
ideally suited to help in tissue repair, cells of this kind that have survived the initial 
inflammatory insult may be important in this process. Alternatively, some recruited 
monocytes may differentiate into more mature mI with repair functions, as has been 
described for monocytes infiltrating the damaged heart and after depletion of liver 
Kupffer cells.198, 199 Inflammatory monocytes themselves have been shown to inhibit 
the pathological effects of neutrophils during the intestinal inflammation induced by 
DSS or Toxoplasma gondii.154, 174 In the latter case, this reflected synthesis of PGE2 
by monocytes174 and other work has confirmed enhanced PGE2 production by 
monocytes during colitis.134 Production of GM-CSF and VEGF-C during 
inflammation may reprogramme the differentiation of monocytes into mI that 
produce reparative mediators such as arginase, prostaglandins and IL-13.200, 201 Thus 
the overall role of the monocyte-mI lineage in intestinal inflammation may reflect a 
balance between local pathogenic and regulatory mechanisms. 
 
Human Intestinal Macrophages  
MI show a similar distribution along the human GI tract and they share the 
morphological features of their mouse counterparts, as well as being refractory to 
stimulation and expressing MHCII and phagocytic receptors.85, 107, 118, 202-205 However 
many phenotypic markers of the myeloid lineage including CD11b, F4/80 and CD11c 
are not conserved between the species and a variety of different markers need to be 
used to distinguish human intestinal mI from cDC, including CD14, CD33, CD64 
and CD68.5 CD163 or CD206 are also expressed by most mature mI in humans, but 
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they express low amounts of CD14, which is found at high levels on classical 
monocytes and immature mI. 85, 107, 118, 202-205 
Using markers of this kind, it can be shown that a monocyte-mI “waterfall” 
exists in the normal human intestine, with some CD14hi monocytes being present, 
together with intermediary stages and a major population of CD14loCD163+CD206+ 
mI.5, 107 Interestingly, recent studies in human BM transplantation have suggested that 
as in mice, human intestinal mI are continuously replenished by circulating 
precursors (Dr M. Haniffa, University of Newcastle, Personal Communication). 
Nevertheless, there may be some differences between mI in steady state human and 
mouse intestine. Thus human intestinal mI are capable of producing RA via 
expression of the Aldh1a1 gene whereas in mice, RA production appears limited to 
cDC.84, 85 Furthermore, as we have noted earlier, TGFE may play a more important 
role in the hyporesponsiveness of human intestinal mI to TLR stimulation than it 
does in mice.142 Indeed, there appear to be several differences in how responsiveness 
to pattern recognition receptors is regulated in human and murine mI in general.206 As 
in mice however, IL-10 plays an essential role in controlling the pro-inflammatory 
potential of human intestinal mI and non-functional mutations in the IL-10R lead to 
severe, early onset IBD.136-138 The mucosa in Crohn’s disease also shows evidence of 
open chromatin in the pro-inflammatory gene loci normally silenced by IL-10.140 
As in mice, studies of human inflammatory bowel disease have highlighted 
the presence of large numbers of classical (CD14hi) monocytes and a relatively 
decreased frequency of mature mI.84, 85, 107, 175, 207-209 Furthermore, these immature 
cells are responsible for producing large amounts of the pro-inflammatory mediators 
that typify these disorders, including TNFD, IL-1, IL-18, IL-23, nitric oxide (NO) and 
reactive oxygen intermediates (ROI).128, 202, 203, 207, 210, 211 Production of RA by 
infiltrating monocytes and mI may also be enhanced during IBD, perhaps secondary 
to increased levels of GM-CSF.85 Interestingly, autocrine signalling via the RA 
receptor has been suggested to contribute to the production of TNFD by mI.85  
 
Environmental Conditioning of Intestinal Monocytes and Macrophages 
 
As with cDC, the characteristics of intestinal mIset them apart from their 
counterparts in other tissues and reveal a role for the local environment in imprinting 
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their properties. Thus we have found that although mI in the dermis and intestine are 
both derived from classical monocytes,115, 212 these cells show transcriptional 
differences very soon after arriving in the two tissues, becoming increasingly distinct 
as they develop into mature mI.143 TGFE again may play a central role in the terminal 
differentiation of monocytes into intestinal mI. TGFE is known to upregulate 
CX3CR1 on other mI213 and mice lacking KLF10, a transcription factor involved in 
the TGFER pathway, have reduced numbers of intestinal CX3CR1hi mI.214 TGFE 
does not seem to be required for the initial stages of monocyte recruitment and 
maturation, consistent with the findings from other tissues that a number of different 
factors need to act in concert to specify resident mI differentiation.215 Active 
epigenetic marking of the enhancer of the Runt-related transcription factor 3 (Runx-3) 
was also recently shown to be a selective feature of resident intestinal mI216and 
Runx-3 is known to interact with TGFEsignalling in other cells including Langerhans 
cells.217 However its role in intestinal mI development has not been explored directly. 
RA is required for the development of the CD169+ subset of intestinal mI but not of 
other intestinal mI 93, 106, 218 and dietary amino acids such as glutamine have also been 
proposed to be important for mI development in the small intestine.219  
A number of mechanisms may help drive the production of IL-10 by intestinal 
mI, including products of the microbiota such as the SCFA butyrate 97, 220 or ligands 
for the MyD88 signalling pathway,104, 133, 139, 221 as well as for the AhR 96 and PPAR 
receptor pathways.222, 223 Intestinal mI in Cx3cr1-/- mice show a defective IL-10 
production 39 and fractalkine (CX3CL1), the only ligand for CX3CR1 downregulates 
NF-NB and pro-inflammatory cytokine production in BM derived mI via 
PPARJsignalling.224 Thus there could be links between these pathways in the 
regulatory functions of intestinal mI. IL-10 itself can also drive some of the 
properties of intestinal mIin addition to their hyporesponsiveness to stimulation, 
including the expression of scavenger receptors such as CD163.122, 133 
Finally, although there is much reduced recruitment of monocytes to the colon of 
germ free mice compared with conventionally housed controls,115 mature mI remain 
present in germ free colon, indicating the microbiota does not play an essential role in 
their development. However the production of IL-1E by intestinal mI is dependent on 
the presence of the microbiota 124, 161 and exposure to the microbiota can also act as a 
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feedback mechanism by limiting the generation of active IL-1E from pro-IL-1E.225 
Whether there are additional effects on mI differentiation and function remains to be 
determined.   
 
6. Summary 
The normal intestinal mucosa contains large populations of cDC and mI 
which play distinct, but complementary roles in local immune responses and tissue 
homeostasis. Whereas cDC are specialised in sampling the microenvironment, 
carrying antigens to the draining LN and shaping the nature and location of 
subsequent T cell responses, mI are sessile scavengers that clear microbes and 
contribute to tissue remodelling, as well as helping to maintain an anti-inflammatory 
milieu in the mucosa. Both populations have properties that make them distinct from 
their counterparts in other tissues, reflecting adaptation to the special demands and 
characteristics of the intestine. As well as containing a unique subset of IRF4 
dependent SIRPD+ DC that expresses both, CD103 and CD11b, cDC from the small 
intestine have an enhanced ability to produce RA and promote the generation of gut-
homing T cells. Intestinal SIRPD+ cDC have been associated with the generation of 
mucosal Th17 and Th2 responses, and XCR1+ cDC with the induction of Th1 
immunity, cross-priming of CD8+ T cells, generation of gut tropic T cells and 
establishment/maintenance of the intestinal IEL compartment. In contrast both cDC 
branches appear to contribute to mucosal iTreg induction. Whether these functions are 
hard-wired or vary depending on context remains to be fully explored. 
Unlike resident mI in many other tissues, those in the intestine require 
constant replenishment from circulating classical monocytes that differentiate locally 
after their arrival in the mucosa, under tissue specific control. This allows constant 
surveillance of the intestine and the opportunity to react rapidly and flexibly to 
changes in its environment. Under inflammatory conditions, the local differentiation 
process that normally generates mature, anti-inflammatory mI from the same 
monocyte precursors is dysregulated, allowing accumulation of pro-inflammatory 
cells with pathological functions. 
Understanding more about the factors that determine the tissue-specific 
properties of intestinal cDC and mI and how these cells change in response to 
inflammation or infection will be important challenges for the future. 
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Figure legends 
 
Figure 1. Identification of intestinal mononuclear phagocyte subsets by flow 
cytometry.  
Representative analysis of small intestinal LP cells pre-gated on live CD45+ cells. A, 
Following exclusion of lineage (CD3, CD19, B220, NK-1.1), cells of the 
monocyte/mI lineage are identified as CD64+, whereas cDC fall into the CD11chi 
CD64- fraction. B, Bona-fide cDC are further characterized by high expression of 
MHCII and can be divided into XCR1+ and SIRPD+ subsets. C, XCR1+ cDC are 
almost entirely CD103+CD11b-, whereas SIRPD+ cDC are heterogeneous and 
comprise CD103+CD11b+ and CD103-CD11b+ cDC, together with a minor population 
of CD103-CD11b- cDC. D, Using Cx3cr1GFP/+ reporter mice, the monocyte/mI lineage 
can be subdivided into CD11b+CX3CR1int cells and CD11b+CX3CR1hi cells. The 
CD11b+CX3CR1int cells contain a mixture of monocytes and mI precursors, which 
can be further classified into a “monocyte waterfall” as Ly6ChiMHCII- recently 
recruited monocytes (P1), Ly6ChiMHCII+ maturing monocytes (P2) and Ly6C-
MHCII+ monocyte/mI intermediates (P3); the CD11b+CX3CR1hi cells consist 
exclusively of Ly6C-MHCII+ tissue-resident mI. 
 
Figure 2. Functions of intestinal cDC. 
 A, cDC functions in the small intestinal LP. Sensing of flagellin via TLR5 or 
Citrobacter rodentium by SIRPD+CD103+CD11b+ cDC and potentially 
SIRPD+CD103-CD11b+ cDC may induce IL-23 secretion, leading to ILC3 activation 
and IL-22 secretion. IL-23 production by SIRPD+ cDC has also been described to 
limit IL-12 secretion by XCR1+ cDC. XCR1+ cDC are the predominant APC that 
takes up cell-derived antigen for cross-presentation to CD8+ T cells. In addition they 
have been shown to promote the development of CD8DD+CD4+ cytotoxic IEL via the 
generation of active TGFE through integrin DvE8 and to sustain the survival of 
intestinal T cells via the XCR1/XCL1 axis. Finally XCL1 production by intestinal 
lymphocytes has been implicated in inducing CCR7 expression in XCR1+ cDC, 
promoting their migration to MLN. B, cDC functions in the intestinal lymph nodes. 
XCR1+ cDC are superior at inducing CD8+ T cell responses to cross-presented 
antigen and are the major cDC subset that produces retinoic acid (RA), inducing 
CCR9 expression on responding CD4+ (brown cells) and CD8+ (blue cells) T cells. 
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They also promote Th1 induction, but dampen the development of Th2 responses via 
release of IL-12. SIRPD+ cDC are specialized in the induction of Th2 and Th17 
responses. Both XCR1+ and SIRPD+ cDC have been implicated in iTreg conversion. 
Similar DC dependent processes are likely to occur in the colon and its draining 
lymph nodes, although many of these have not been explored directly in this tissue. 
 
Figure 3. Intestinal mIin health and inflammation.  
A, In steady state adult intestine, Ly6Chi monocytes are recruited continuously from 
the bloodstream in a CCR2 dependent manner. After arrival in the mucosa, they 
develop through the “monocyte waterfall”, in which LyChiMHCII-CX3CR1intF4/80lo 
monocytes (“P1”) acquire MHCII (“P2”), before losing Ly6C to become Ly6C-
MHCII+F4/80+ monocyte/macrophage intermediaries (“P3”) and finally acquiring 
high levels of CX3CR1 as they terminally differentiate into the majority population of 
resident macrophages (“P4”). This process is determined by factors specific to the 
intestinal microenvironment, with the final step being at least partly dependent on 
TGFE. The resident macrophages engage in important homeostatic functions, as they 
have avid phagocytic activity, express scavenger receptors, metalloproteases and 
produce cytokines and chemokines. As a result, the macrophages can clear effete 
tissue cells and bacteria that cross the epithelium, contribute to tissue remodelling, 
recruit further monocytes and interact with local immune cells such as T cells and 
ILC. They also send processes through the epithelium to capture luminal antigens and 
can transfer antigen to neighbouring migratory cDC via Connexin 43 (Cx43). All 
these activities take place without inflammation occurring, due to IL-10 from T cells 
and macrophages preventing activation and also because of intrinsic mechanisms that 
inhibit PRR signalling in macrophages. IL-10 produced by resident macrophages also 
drives secondary expansion and survival of FoxP3+ Treg that have been primed in 
lymph nodes.  
B, Mucosal inflammation can be caused by invasive pathogens, damage to the 
epithelial barrier leading to increased exposure to commensal bacteria, or to defects in 
macrophage control pathways such as NOD2 or IL-10 function. Under these 
circumstances, there is enhanced recruitment of Ly6Chi monocytes and the normal 
differentiation process is disrupted, allowing accumulation of pro-inflammatory 
monocytes and early intermediary macrophages. These release inflammatory 
  29 
mediators such as nitric oxide (NO), reactive oxygen intermediaries (ROI), TNFD, IL-
12, IL-23, IL-6 and IL-1E which cause tissue damage, as well as activating other 
inflammatory cells including Th1 or Th17 effector cells. Pre-existing resident 
macrophages may contribute to these inflammatory events, or may remain poised to 
initiate tissue repair when required. Monocytes can also help limit pathology by 
releasing PGE2, which inhibits the harmful effects of neutrophils.  
 
Table legends 
Table 1: Conventional DC subsets in the intestine. 
Summary of the phenotypic markers, ontogeny, key functions and relative abundance 
of intestinal cDC subsets. GF – growth factors; TF – transcription factors; siLP – 
small intestinal lamina propria; coLP -colonic lamina propria. 
  
Table 2: Monocytes and mI in the intestine. 
Summary of the phenotypic markers, ontogeny and key functions of intestinal mIand 
their monocyte precursors. See main text for detail. GF – growth factors; TF – 
transcription factors; siLP – small intestinal lamina propria. 
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